Latest VLON reports update at 2023-11-14: 2023-Q32022-Q42022-Q3
Vallon Pharmaceuticals logo

Vallon Pharmaceuticals VLON

$ 0.43 -6.47%

Country

usaUSA

IPO year

2021

Industry

Biotechnology

Stock Exchange

NASDAQ GLOBAL

CEO

Mr. David C. Baker

Employees in the company

2

Shares

6.54 M

Market Cap[1]

$ 5.76 M

EBITDA (LTM)

$ -5.36 M

P/E (LTM)

-0.05

P/S (LTM)

-

EPS (LTM)

-9.03

Other stocks of industry "Biotechnology"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.